Related Experiment Video
Updated: Mar 20, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Clinical differences between elderly and non-elderly chronic subdural hematoma patients
Yongxiang Yang1, Dongbo Zou1, Yuan Ma1
1Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China.
Insights
Elderly patients with chronic subdural hematoma (CSDH) are more likely female, less likely to have trauma, and more likely to use anticoagulants/antiplatelet drugs. They also show higher recurrence rates and longer hospital stays compared to younger individuals.
Area of Science:
- Neurosurgery
- Geriatric Medicine
- Neurology
Background:
- Chronic subdural hematoma (CSDH) is prevalent in the elderly.
- Understanding clinical differences between elderly and non-elderly CSDH patients is crucial for tailored treatment.
Purpose of the Study:
- To investigate and clarify the clinical distinctions between elderly and non-elderly patients diagnosed with chronic subdural hematoma (CSDH).
Main Methods:
- A retrospective study analyzed 268 elderly and 87 non-elderly CSDH patients from January 2015 to December 2024.
- Data collected included baseline clinical features, radiological outcomes, treatment methods, and clinical outcomes.
Main Results:
- Elderly CSDH patients were more frequently female, less commonly associated with trauma, and more often had a history of anticoagulant/antiplatelet use (P < 0.05).
- Elderly patients exhibited thicker, larger hematomas, more frequent atorvastatin use, higher recurrence rates, and longer hospital stays (P < 0.05).
Conclusions:
- Elderly CSDH patients present with distinct clinical profiles, including less trauma history and increased anticoagulant/antiplatelet use.
- Higher rates of atorvastatin use and hematoma recurrence are observed in elderly CSDH patients compared to their non-elderly counterparts.
Objective:
Chronic subdural hematoma (CSDH) is a common disease in elderly population, which can also be seen in young and middle-aged individuals. In order to understand the clinical features of this disease deeply, we conducted this retrospective study to clarify the clinical differences between elderly and non-elderly CSDH patients.
Methods:
According to the inclusion and exclusion criteria, 268 elderly CSDH patients and 87 non-elderly CSDH patients were recruited from January 2015 to December 2024 in our cohort. The collected data and compared parameters including baseline clinical features and radiological outcomes of hematoma within 24 h of hospital admission, as well as the treatment method and clinical outcome of elderly and non-elderly CSDH patients.
Results:
Compared to non-elderly CSDH patients, female was more frequent, the traumatic events were less common, and the history of taking anticoagulants and antiplatelet drugs were more common in elderly CSDH patients (all P < 0.05). Moreover, the hematoma was thicker and larger, the usage of atorvastatin was more common, the recurrence rate was higher, and the mean hospital stay was longer in elderly CSDH patients than in non-elderly CSDH patients (all P < 0.05).
Conclusion:
Elderly CSDH patients were less likely to have the traumatic events and more likely to have the history of taking anticoagulants/antiplatelet drugs, who were also owing the higher rate of using atorvastatin and hematoma recurrence, compared to non-elderly CSDH patients.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
08:07Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism